Action Collaborative on Combatting Substance Use and Opioid Crises Members
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

Steering Committee
The Steering Committee provides guidance and strategic direction for the Action Collaborative and oversees the activities of the working groups.

Victor J. Dzau, MD, is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine (IOM). In addition, he serves as Vice Chair of the National Research Council. Dr. Dzau is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Bloomfield Professor and Chairman of the Department of Medicine at Stanford University.
Dr. Dzau is an internationally acclaimed physician scientist and leader whose work has improved health and medicine in the United States and globally. His seminal work in cardiovascular medicine and genetics laid the foundation for the development of the class of lifesaving drugs known as ACE inhibitors, used globally to treat hypertension and heart failure. Dr. Dzau pioneered gene therapy for vascular disease and was the first to introduce DNA decoy molecules in humans in vivo. His pioneering research in cardiac regeneration led to the Paracrine Hypothesis of stem cell action and his recent strategy of direct cardiac reprogramming using microRNA. He maintains an active NIH-funded research laboratory.
Dr. Dzau is a leader in health and heath policy. At the NAM, he has led important initiatives such as Vital Directions for Health and Health Care, the Action Collaborative on Countering the US Opioid Epidemic, and the Action Collaborative on Clinician Well-Being and Resilience. Under his tenure, the NAM has advanced efforts to improve health equity and address racism throughout its programmatic activities, especially the Culture of Health Program. Most recently, the NAM launched a Grand Challenge in Climate Change and Human Health & Equity to reverse the negative effects of climate change on health and social equity by activating the entire biomedical community, communicating and educating the public about climate change and health, driving changes through research, innovation and policy, and leading bold action to decarbonize the health care sector.
As a global health leader, he helped design and launch the National Academies initiatives on Global Health Risk Framework; Global Health and Future Role of the US; Crossing the Global Quality Chasm and Human Genome Editing. The NAM Global Grand Challenge for Healthy Longevity represents his vision to inspire across disciplines and sectors to coalesce around a shared priority and audacious goal to advance health.
He has led the NAM’s response to COVID-19, which includes numerous committees, reports, consultations and communication on a range of issues including public health, vaccine allocation, health equity and mental health. He has worked tirelessly to engage with the global response to COVD-19 by providing leadership as a member of the Global Preparedness Monitoring Board, co-chair of the G20 Scientific Expert Panel on Global Health Security, Advisor to the G20 High Level Independent Panel on Financing and a principal of the ACT-Accelerator which includes COVAX, the global collaboration for accelerating the development, manufacture and equitable distribution of COVID-19 vaccines.
He is active in advising science and health in US and globally. He has served as a member of the Advisory Committee to the Director of the National Institutes of Health (NIH), chaired the NIH Cardiovascular Disease Advisory Committee and NHLBI Cardiovascular Progenitor Cell Biology Consortium. Currently, he chairs the Cardiovascular Progenitor Cell Translational Consortium. He is a member of the Health and Biomedical Sciences International Advisory Council of Singapore, as well as a board member of the Imperial College Health Partners, UK and the Gairdner Foundation. He chairs the International Scientific Advisory Committee of the Qatar Precision Medicine Institute, the Scientific Boards of the Peter Munk Cardiac Center, University of Toronto and Institute of Cardiovascular and Medical Sciences, University of Glasgow. He served on the Board of Health Governors of the World Economic Forum and chairs its Global Futures Council on Healthy Longevity.
Among his many honors and recognitions are the Max Delbreck Medal from Charite, Humboldt and Max Planck, Germany, the Distinguished Scientist Award from the American Heart Association, Ellis Island Medal of Honor, and the Henry Freisen International Prize. In 2019, he was named an Honorary Citizen of Singapore- the highest level of honor bestowed to a foreign citizen conferred by the President of Singapore. He has been elected to the National Academy of Medicine, the American Academy of Arts and Sciences, the European Academy of Sciences and Arts, UK Academy of Medical Sciences, the Japan Academy, Mexican Academy of Medicine, Chinese Academy of Engineering and Academia Sinica. He has received 16 honorary doctorates.





Learning A Lot About A Lot
The path Dr. Humayun “Hank” Chaudhry took to become president and CEO of the Federation of State Medical Boards (FSMB) was far from conventional. He never saw himself in a health executive role- he simply wanted to work directly with patients in clinical settings. This was reflected in his choice to pursue primary care. Dr. Chaudhry chose to train in internal medicine so he could address a wide range of patient needs and “learn a lot about a lot”. He wanted to help as many patients as possible and not limit his care by focusing on a single organ. After graduating from New York Institute of Technology’s College of Osteopathic Medicine, Dr. Chaudhry served as a reservist for 14 years in the United States Air Force where he became a flight surgeon. During those formative years of his military career Dr. Chaudhry learned to balance his work and family life while serving the nation. It was during his time in the Air Force that he expanded his role as an educator and learned to function in an ultra-structured environment.
Dr. Chaudhry was first exposed to the administrative side of medicine when he became the director of medical education and a designated institutional official (DIO) at Long Beach Medical Center, New York. During his experience as DIO, he was responsible for assuring training compliance with the American Ostopathic Association institutional, common, and specialty-specific program requirements, as well as additional professional, educational, accreditation, and regulatory standards. After being responsible for leading medical students and residents through their medical training, Dr. Chaudhry decided to formally learn more about the science of leadership.
Learning to Lead
Dr. Chaudhry earned a Master’s degree in health management at the Harvard T.H. Chan School of Public Health in 2001. During his studies, he learned about various leadership styles and began to understand how health policy, administration, and organizational management intersect and can directly improve population health.
When he saw an opportunity to care for the health care needs of 1.5 million people Dr. Chaudhry recognized those familiar intersecting forces and chose to alter his entire career trajectory. In 2007, Dr. Chaudhry became Health Commissioner of Suffolk County in New York. As a clinician, he’d seen patients one at a time. Now he was responsible for overseeing the health and well-being of the county’s entire population and a $400 million budget. Just two years into his tenure as Commissioner, Dr. Chaudhry was presented with a challenge few health departments and officials ever want to face – the pandemic H1N1 influenza outbreak.
During the H1N1 outbreak, Dr. Chaudhry learned about the importance of messaging and communication, and of staying calm, being nimble, and being able to bring together the right people. These strengths would stay with him and carry him through the rest of his career. Dr. Chaudhry said the pandemic helped him learn that “there’s always time to bring together the right people, think through the issues, and develop a plan of action.” The approaches he took as Commissioner are the same ones he’s using in his role today at the FSMB, which includes addressing the opioid epidemic.
A New Focus for FSMB
Founded in 1912, the FSMB’s primary responsibility has always been supporting America’s state and territorial medical boards as they protect the public through licensing, discipline, and regulation of physicians and other health professionals. In 1992, the FSMB became a co-sponsor of the United States Medical Licensing Examination (USMLE). For more than a decade, the opioid epidemic has prompted FSMB to do more to raise awareness among medical student, residents, and practicing clinicians about responsible opioid prescribing.
Through continuing medical education, a new focus for FSMB, it helps member boards ensure that as standards of care change and new medical evidence becomes available, practicing clinicians learn how to apply that understanding. By working with such federal agencies as the Centers for Disease Control and Prevention, the FSMB has issued policies and recommendations about opioid prescribing to enable state medical boards to improve the quality of health care.
The USMLE is used to assess a physician’s readiness for practice and to apply, concepts, and principles, and to advance patient-centered care skills. As a co-sponsor of the USMLE, the FSMB is able to influence how future clinicians are being educated and trained. In recent years, that has included promoting the assessment of knowledge and skills about pain management, addiction and opioid and other substance use disorders.
Joining the Opioid Action Collaborative
Each time Dr. Chaudhry visits with members boards, they share with him their ongoing concerns about the opioid epidemic. They describe the heartbreaking stories of patients or their loved ones who have died from an opioid overdose or misuse and the licensed physicians who either did not perceive a problem until it was too late or, worse, were complicit in the outcomes. Because medical regulation is complaint-based, a big challenge for member boards is not hearing from patients and their loved ones until the situation is too late. Members of the medical profession, Dr. Chaudhry notes, also have a duty to report problems they may see in health care.
The tragic stories Dr. Chaudhry hears about and the interests of state medical boards align with the solutions and issues being addressed by the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic. For Dr. Chaudhry, that meant it was a “no brainer” to join the steering committee and help make a difference. He wants to help assure the alignment of goals across the four working groups of the Opioid Action Collaborative and ensure implementable solutions are being prioritized.
Dr. Chaudhry sees the Action Collaborative as different from other efforts he has been involved with because of its emphasis on action. “A lot of organizations put together guidelines and recommendations that may or may not be read or acted upon. This group has expressed a desire to measure the outcomes of the recommendations we make.”
From the beginning of his career, Dr. Chaudhry has wanted to learn “a lot about a lot” and over the course of his career he has expanded his knowledge base to encompass leadership, medical education, health administration, and public health. It is this motivation that leads him to learn more from the clinicians and patients he talks with to help develop solutions to address their needs, to serve on the NAM Opioid Action Collaborative steering committee, and to continue to care for as many people as possible.





Action Collaborative Members












































































The Action Collaborative serves as a neutral platform through which to facilitate dialogue and discussion among representatives from multiple sectors around topics of mutual interest and concern. Individual participating members of the Action Collaborative on Combatting Substance Use and Opioid Crises have disclosed any perceived or actual interests (financial, organizational, professional, or personal in nature) relevant to the activities of the Action Collaborative. Summaries of relevant interests reported can be found here.
A full list of our member organizations can be found here.
Contact Information
Questions?
For more information, please contact [email protected]